SCHEMBL7336437

SCHEMBL7336437

CCn1ncc2c(Cl)c3cccc(Br)c3nc21

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
ENPP3 O14638 1/20 0.42
ENPP1 P22413 1/20 0.42
GRM2 Q14416 4/20 0.41
NR3C1 P04150 4/20 0.40
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
HSP90AA1 P07900 1/20 0.37
HSP90B1 P14625 1/20 0.37
TRAP1 Q12931 1/20 0.37
PDE10A Q9Y233 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7331362 0.82 KDM4E (0.52) ALDH1A1NR3C1ADORA3ADORA2AADORA1
SCHEMBL7332532 0.77 MAOA (0.50) ALDH1A1NR3C1ADORA3ADORA2AADORA1
SCHEMBL8442820 0.74 ENPP1 (0.61) ALDH1A1ENPP3ENPP1GRM2ADORA1
SCHEMBL7328414 0.73 RXFP1 (0.50) ALDH1A1NR3C1ADORA3ADORA2AADORA1
SCHEMBL7332774 0.73 PDE5A (0.41) GRM2ADORA2AADORA1
SCHEMBL7428137 0.69 NR3C1 (0.46) ALDH1A1NR3C1ADORA3ADORA2AADORA1
SCHEMBL18070761 0.68 GRM2 (0.51) GRM2KDM4E
SCHEMBL15228801 0.68 ALDH1A1 (0.45) ALDH1A1ENPP3ENPP1GRM2KDM4E
SCHEMBL13612893 0.67 ADORA3 (0.40) ALDH1A1NR3C1ADORA3ADORA2AADORA1
SCHEMBL7332950 0.67 ADORA2A (0.38) NR3C1ADORA3ADORA2AADORA1PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5942520-A Method for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 amines CELL PATHWAYS, INC. (US) 1999-08-24 US disclosed
US-5488055-A ADMINISTERING GMP HOSPHODIESTERASE INHIBITORS FOR TREATMENT OF CONGESTIVE HEART FAILURE AND CARDIOVASCULAR DISORDERS SANOFI WINTHROP INC. (US) 1996-01-30 US disclosed